Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy
Open Access
- 16 November 2017
- journal article
- Published by American Society of Hematology in Blood Advances
- Vol. 1 (25) , 2320-2324
Abstract
Key Points: There is currently no clear consensus on the best approach to the management of patients with APS and arterial thrombosis. Combined antiplatelet and anticoagulant therapy may decrease risk of thrombosis recurrence in patients with APS and arterial thrombosis.Keywords
This publication has 13 references indexed in Scilit:
- Diagnosis and classification of the antiphospholipid syndromeJournal of Autoimmunity, 2014
- Pathogenesis of antiphospholipid syndrome: understanding the antibodiesNature Reviews Rheumatology, 2011
- Antiphospholipid Syndrome Clinical Research Task Force ReportLupus, 2011
- Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndromeInternational Journal of Medical Sciences, 2010
- Controversies and Unresolved Issues in Antiphospholipid Syndrome Pathogenesis and ManagementHematology/Oncology Clinics of North America, 2008
- Management of Antiphospholipid Antibody SyndromeJAMA, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic StrokeJAMA, 2004
- A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody SyndromeNew England Journal of Medicine, 2003
- A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic StrokeNew England Journal of Medicine, 2001